Document and Entity Information
Document and Entity Information - shares | 3 Months Ended | |
Mar. 31, 2024 | May 06, 2024 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Amendment Flag | false | |
Document Period End Date | Mar. 31, 2024 | |
Document Fiscal Year Focus | 2024 | |
Document Fiscal Period Focus | Q1 | |
Trading Symbol | RDVT | |
Entity Registrant Name | RED VIOLET, INC. | |
Entity Central Index Key | 0001720116 | |
Current Fiscal Year End Date | --12-31 | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | false | |
Entity Common Stock, Shares Outstanding | 13,730,543 | |
Entity Current Reporting Status | Yes | |
Entity Shell Company | false | |
Entity File Number | 001-38407 | |
Entity Tax Identification Number | 82-2408531 | |
Entity Address, Address Line One | 2650 North Military Trail | |
Entity Address, Address Line Two | Suite 300 | |
Entity Address, City or Town | Boca Raton | |
Entity Address, State or Province | FL | |
Entity Address, Postal Zip Code | 33431 | |
City Area Code | 561 | |
Local Phone Number | 757-4000 | |
Entity Information, Former Legal or Registered Name | None | |
Document Transition Report | false | |
Document Quarterly Report | true | |
Entity Interactive Data Current | Yes | |
Entity Incorporation, State or Country Code | DE | |
Title of 12(b) Security | Common Stock, $0.001 par value per share | |
Security Exchange Name | NASDAQ |
CONDENSED CONSOLIDATED BALANCE
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
Current assets: | ||
Cash and cash equivalents | $ 32,147 | $ 32,032 |
Accounts receivable, net of allowance for doubtful accounts of $212 and $159 as of March 31, 2024 and December 31, 2023, respectively | 7,871 | 7,135 |
Prepaid expenses and other current assets | 1,491 | 1,113 |
Total current assets | 41,509 | 40,280 |
Property and equipment, net | 601 | 592 |
Intangible assets, net | 34,962 | 34,403 |
Goodwill | 5,227 | 5,227 |
Right-of-use assets | 2,323 | 2,457 |
Deferred tax assets | 9,043 | 9,514 |
Other noncurrent assets | 361 | 517 |
Total assets | 94,026 | 92,990 |
Current liabilities: | ||
Accounts payable | 2,353 | 1,631 |
Accrued expenses and other current liabilities | 4,741 | 1,989 |
Current portion of operating lease liabilities | 588 | 569 |
Deferred revenue | 652 | 690 |
Total current liabilities | 8,334 | 4,879 |
Noncurrent operating lease liabilities | 1,845 | 1,999 |
Total liabilities | 10,179 | 6,878 |
Shareholders' equity: | ||
Preferred stock-$0.001 par value, 10,000,000 shares authorized, and 0 share issued and outstanding, as of March 31, 2024 and December 31, 2023 | 0 | 0 |
Common stock-$0.001 par value, 200,000,000 shares authorized, 13,942,164 and 13,980,274 shares issued, and 13,740,164 and 13,970,846 shares outstanding, as of March 31, 2024 and December 31, 2023 | 14 | 14 |
Treasury stock, at cost, 202,000 and 9,428 shares as of March 31, 2024 and December 31, 2023 | (4,143) | (188) |
Additional paid-in capital | 94,065 | 94,159 |
Accumulated deficit | (6,089) | (7,873) |
Total shareholders' equity | 83,847 | 86,112 |
Total liabilities and shareholders' equity | $ 94,026 | $ 92,990 |
CONDENSED CONSOLIDATED BALANC_2
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
Statement of Financial Position [Abstract] | ||
Allowance for doubtful accounts | $ 212 | $ 159 |
Preferred stock, par value | $ 0.001 | $ 0.001 |
Preferred stock, shares authorized | 10,000,000 | 10,000,000 |
Preferred stock, shares issued | 0 | 0 |
Preferred stock, shares outstanding | 0 | 0 |
Common stock, par value | $ 0.001 | $ 0.001 |
Common stock, shares authorized | 200,000,000 | 200,000,000 |
Common stock, shares issued | 13,942,164 | 13,980,274 |
Common stock, shares outstanding | 13,740,164 | 13,970,846 |
Treasury stock shares | 202,000 | 9,428 |
CONDENSED CONSOLIDATED STATEMEN
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | ||
Mar. 31, 2024 | Mar. 31, 2023 | ||
Revenue | $ 17,511 | $ 14,626 | |
Costs and expenses: | |||
Sales and marketing expenses | 3,712 | 3,889 | |
General and administrative expenses | 5,790 | 5,241 | |
Depreciation and amortization | 2,270 | 1,916 | |
Total costs and expenses | 15,528 | 14,225 | |
Income from operations | 1,983 | 401 | |
Interest income, net | 365 | 286 | |
Income before income taxes | 2,348 | 687 | |
Income tax (benefit) expense | 564 | (29) | |
Net income | $ 1,784 | $ 716 | |
Earnings per share: | |||
Basic | $ 0.13 | $ 0.05 | |
Diluted | $ 0.13 | $ 0.05 | |
Weighted average number of shares outstanding: | |||
Basic | 13,997,064 | 13,997,154 | |
Diluted | [1] | 14,164,506 | 14,236,771 |
Service [Member] | |||
Costs and expenses: | |||
Cost of revenue (exclusive of depreciation and amortization) | $ 3,756 | $ 3,179 | |
[1] For the three months ended March 31, 2024 and 2023, diluted weighted average shares outstanding are calculated by the inclusion of unvested restricted stock units ("RSUs"). |
CONDENSED CONSOLIDATED STATEM_2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Unaudited) - USD ($) $ in Thousands | Total | Common Stock | Treasury stock | Additional Paid- in Capital | Accumulated Deficit |
Beginning balance at Dec. 31, 2022 | $ 71,093 | $ 14 | $ 92,481 | $ (21,402) | |
Beginning balances, shares at Dec. 31, 2022 | 13,956,404 | ||||
Vesting of restricted stock units, Shares | 6,800 | ||||
Increase in treasury stock resulting from shares withheld to cover statutory taxes | (31) | $ (31) | |||
Increase in treasury stock resulting from shares withheld to cover statutory taxes, Shares | (1,561) | ||||
Retirement of treasury stock | 31 | $ 31 | (31) | ||
Retirement of treasury stock, Shares | (1,561) | 1,561 | |||
Common stock repurchased | (201) | $ (201) | |||
Common stock repurchased, shares | (10,937) | ||||
Share-based compensation | 1,843 | 1,843 | |||
Net income | 716 | 716 | |||
Ending balance at Mar. 31, 2023 | 73,420 | $ 14 | $ (201) | 94,293 | (20,686) |
Ending balances, shares at Mar. 31, 2023 | 13,961,643 | (10,937) | |||
Beginning balance at Dec. 31, 2023 | 86,112 | $ 14 | $ (188) | 94,159 | (7,873) |
Beginning balances, shares at Dec. 31, 2023 | 13,980,274 | (9,428) | |||
Vesting of restricted stock units, Shares | 67,125 | ||||
Increase in treasury stock resulting from shares withheld to cover statutory taxes | (383) | $ (383) | |||
Increase in treasury stock resulting from shares withheld to cover statutory taxes, Shares | (20,867) | ||||
Retirement of treasury stock | 1,942 | $ 1,942 | (1,942) | ||
Retirement of treasury stock, Shares | (105,235) | 105,235 | |||
Common stock repurchased | (5,514) | $ (5,514) | |||
Common stock repurchased, shares | (276,940) | ||||
Share-based compensation | 1,848 | 1,848 | |||
Net income | 1,784 | 1,784 | |||
Ending balance at Mar. 31, 2024 | $ 83,847 | $ 14 | $ (4,143) | $ 94,065 | $ (6,089) |
Ending balances, shares at Mar. 31, 2024 | 13,942,164 | (202,000) |
CONDENSED CONSOLIDATED STATEM_3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
CASH FLOWS FROM OPERATING ACTIVITIES: | ||
Net income | $ 1,784 | $ 716 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||
Depreciation and amortization | 2,270 | 1,916 |
Share-based compensation expense | 1,402 | 1,384 |
Write-off of long-lived assets | 0 | 3 |
Provision for bad debts | 70 | 668 |
Noncash lease expenses | 134 | 145 |
Deferred income tax expense (benefit) | 471 | (30) |
Changes in assets and liabilities: | ||
Accounts receivable | (806) | (1,022) |
Prepaid expenses and other current assets | (378) | (539) |
Other noncurrent assets | 156 | (293) |
Accounts payable | 722 | 116 |
Accrued expenses and other current liabilities | (1,347) | (1,460) |
Deferred revenue | (38) | 93 |
Operating lease liabilities | (135) | (166) |
Net cash provided by operating activities | 4,305 | 1,531 |
CASH FLOWS FROM INVESTING ACTIVITIES: | ||
Purchase of property and equipment | (65) | (44) |
Capitalized costs included in intangible assets | (2,327) | (2,273) |
Net cash used in investing activities | (2,392) | (2,317) |
CASH FLOWS FROM FINANCING ACTIVITIES: | ||
Taxes paid related to net share settlement of vesting of restricted stock units | (383) | (31) |
Repurchases of common stock | (1,415) | (175) |
Net cash used in financing activities | (1,798) | (206) |
Net increase (decrease) in cash and cash equivalents | 115 | (992) |
Cash and cash equivalents at beginning of period | 32,032 | 31,810 |
Cash and cash equivalents at end of period | 32,147 | 30,818 |
SUPPLEMENTAL DISCLOSURE INFORMATION | ||
Cash paid for interest | 0 | 0 |
Cash paid for income taxes | 0 | 1 |
Share-based compensation capitalized in intangible assets | 446 | 459 |
Retirement of treasury stock | $ 1,942 | $ 31 |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 3 Months Ended |
Mar. 31, 2024 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | 1. Summary of significant accounting policies (a) Basis of preparation The accompanying unaudited condensed consolidated financial statements of Red Violet, Inc., a Delaware corporation, and its consolidated subsidiaries (collectively, “red violet” or the “Company”), have been prepared in accordance with accounting principles generally accepted in the United States (“US GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in annual financial statements prepared in accordance with US GAAP have been condensed or omitted pursuant to those rules and regulations. The accompanying unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the financial position, results of operations, and cash flows for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for any future interim periods or for the full year ending December 31, 2024. The information included in this quarterly report on Form 10-Q should be read in conjunction with the consolidated financial statements and accompanying notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 filed with the SEC on March 7, 2024 (“Form 10-K”). The condensed consolidated balance sheet as of December 31, 2023 included herein was derived from the audited financial statements as of that date included in the Form 10-K, but does not include all disclosures required by US GAAP. The Company has only one operating segment, as defined by Accounting Standards Codification (“ASC”) 280, “ Segment Reporting .” Principles of consolidation The condensed consolidated financial statements include the financial statements of the Company and its subsidiaries. All significant transactions among the Company and its subsidiaries have been eliminated upon consolidation. (b) Recently issued accounting standards In December 2023, the Financial Accounting Standard Board (the “FASB”) issued Accounting Standard Updates (“ASU”) No. 2023-09, " Income Taxes (Topic 740): Improvements to Income Tax Disclosures (ASU 2023-09) ," which improves the transparency of income tax disclosures by requiring consistent categories and greater disaggregation of information in the effective tax rate reconciliation and income taxes paid disaggregated by jurisdiction. It also includes certain other amendments to improve the effectiveness of income tax disclosures. This guidance will be effective for the annual periods beginning after December 31, 2024. Early adoption is permitted. Upon adoption, the guidance can be applied prospectively or retrospectively. The Company is currently evaluating the guidance to determine its impact on our condensed consolidated financial statements and related disclosures. |
Earnings per share
Earnings per share | 3 Months Ended |
Mar. 31, 2024 | |
Earnings Per Share [Abstract] | |
Earnings per share | 2. Earnings per share Basic earnings per share is computed by dividing net income by the weighted average number of shares of common stock outstanding during the periods. Diluted earnings per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock and is calculated using the treasury stock method for unvested shares. Three Months Ended March 31, (In thousands, except share data) 2024 2023 Numerator: Net income $ 1,784 $ 716 Denominator: Weighted average shares outstanding: Basic 13,997,064 13,997,154 Diluted (1) 14,164,506 14,236,771 Earnings per share: Basic $ 0.13 $ 0.05 Diluted $ 0.13 $ 0.05 (1) For the three months ended March 31, 2024 and 2023, diluted weighted average shares outstanding are calculated by the inclusion of unvested restricted stock units ("RSUs"). |
Intangible Assets, Net
Intangible Assets, Net | 3 Months Ended |
Mar. 31, 2024 | |
Intangible Assets, Net (Excluding Goodwill) [Abstract] | |
Intangible Assets, Net | 3. Intangible assets, net Intangible assets other than goodwill consist of the following: March 31, 2024 December 31, 2023 (In thousands) Amortization Gross amount Accumulated amortization Net Gross amount Accumulated amortization Net Software developed for internal use 5 - 10 years $ 66,318 $ ( 31,356 ) $ 34,962 $ 63,545 $ ( 29,142 ) $ 34,403 The gross amount associated with software developed for internal use represents capitalized costs of internally-developed software, including eligible salaries and staff benefits, share-based compensation, travel expenses incurred by relevant employees, and other relevant costs. Amortization expenses of $ 2,214 and $ 1,858 for the three months ended March 31, 2024 and 2023, respectively, were included in depreciation and amortization expense. As of March 31, 2024, intangible assets of $ 5,265 , included in the gross amounts of software developed for internal use, have not started amortization, as they are not ready for their intended use. The Company capitalized costs of software developed for internal use of $ 2,773 and $ 2,732 during the three months ended March 31, 2024 and 2023, respectively. As of March 31, 2024, estimated amortization expense related to the Company’s intangible assets for the remainder of 2024 through 2029 and thereafter are as follows: (In thousands) Year March 31, 2024 Remainder of 2024 $ 7,164 2025 8,753 2026 7,301 2027 5,685 2028 3,253 2029 and thereafter 2,806 Total $ 34,962 |
Goodwill
Goodwill | 3 Months Ended |
Mar. 31, 2024 | |
Goodwill Disclosure [Abstract] | |
Goodwill | 4. Goodwill Goodwill represents the cost in excess of the fair value of the net assets acquired in a business combination. As of March 31, 2024 and December 31, 2023, the balance of goodwill of $ 5,227 was as a result of the acquisition of Interactive Data, LLC, a wholly-owned subsidiary of red violet, effective on October 2, 2014. In accordance with ASC 350, “Intangibles - Goodwill and Other,” goodwill is tested at least annually for impairment, or when events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable, by assessing qualitative factors or performing a quantitative analysis in determining whether it is more likely than not that its fair value exceeds the carrying value. The measurement date of the Company’s annual goodwill impairment test is October 1 . The Company did no t record a goodwill impairment loss during the three months ended March 31, 2024 and 2023, and there was no accumulated goodwill impairment loss as of March 31, 2024. |
Revenue Recognition
Revenue Recognition | 3 Months Ended |
Mar. 31, 2024 | |
Revenue from Contract with Customer [Abstract] | |
Revenue Recognition | 5. Revenue recognition The Company recognized revenue in accordance with ASC 606, “Revenue from Contracts with Customers” (“Topic 606”). Under this standard, revenue is recognized when control of goods or services is transferred to the Company’s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. The Company’s performance obligation is to provide on demand information and identity intelligence solutions to its customers by leveraging its proprietary technology and applying machine learning and advanced analytics to its massive data repository. The pricing for the customer contracts is based on usage, a monthly fee, or a combination of both. Available within Topic 606, the Company has applied the portfolio approach practical expedient in accounting for customer revenue as one collective group, rather than individual contracts. Based on the Company’s historical knowledge of the contracts contained in this portfolio and the similar nature and characteristics of the customers, the Company has concluded the financial statement effects are not materially different than if accounting for revenue on a contract by contract basis. Revenue is recognized over a period of time. The Company’s customers simultaneously receive and consume the benefits provided by the Company’s performance as and when provided. Furthermore, the Company has elected the “right to invoice” practical expedient, available within Topic 606, as its measure of progress, since it has a right to payment from a customer in an amount that corresponds directly with the value of its performance completed-to-date. In some arrangements, a right to consideration for the Company's performance under the customer contract may occur before invoicing to the customer, resulting in an unbilled accounts receivable. As of March 31, 2024, the current and noncurrent portion unbilled accounts receivable of $ 841 and $ 216 , respectively, were included within accounts receivable and other noncurrent assets, respectively, on the condensed consolidated balance sheets . As of December 31, 2023, the current and noncurrent portion unbilled accounts receivable of $ 829 and $ 371 , respectively, were included within accounts receivable and other noncurrent assets, respectively , on the consolidated balance sheets. The Company's revenue arrangements do not contain significant financing components. For the three months ended March 31, 2024 and 2023, 78 % and 75 % of total revenue was attributable to customers with pricing contracts, respectively, versus 22 % and 25 % attributable to transactional customers, respectively. Pricing contracts are generally annual contracts or longer, with auto renewal. If a customer pays consideration before the Company transfers services to the customer, those amounts are classified as deferred revenue. As of March 31, 2024 and December 31, 2023, the balance of deferred revenue was $ 652 and $ 690 , respectively, all of which is expected to be realized in the next 12 months. In relation to the deferred revenue balance as of December 31, 2023, $ 264 was recognized into revenue during the three months ended March 31, 2024. As of March 31, 2024, $ 23,174 of revenue is expected to be recognized in the future for performance obligations that are unsatisfied or partially unsatisfied , related to pricing contracts that have a term of more than 12 months, of which, $ 8,932 of revenue will be recognized in the remainder of 2024, $ 7,659 in 2025, $ 3,669 in 2026, $ 2,582 in 2027, $ 287 in 2028, and $ 45 in 2029. The actual timing of recognition may vary due to factors outside of the Company’s control. The Company excludes variable consideration related entirely to wholly unsatisfied performance obligations and contracts and recognizes such variable consideration based upon the right to invoice the customer. Sales commissions are incurred and recorded on an ongoing basis over the term of the customer relationship. These costs are recorded in sales and marketing expenses. In addition, the Company elected the practical expedient to not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which the Company recognizes revenue at the amount to which it has the right to invoice for services performed. |
Income Taxes
Income Taxes | 3 Months Ended |
Mar. 31, 2024 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | 6. Income taxes The Company is subject to federal and state income taxes in the United States. The Company’s tax provision for interim periods is determined using an estimate of its annual effective tax rate, adjusted for discrete items arising in that quarter, unless a reliable estimate of ordinary income or the related tax expense/benefit cannot be made or the Company is in cumulative losses for which the benefit cannot be realized. In each quarter, the Company updates its estimate of the annual effective tax rate, and if its estimated annual tax rate changes, the Company makes a cumulative adjustment in that quarter. Prior to the third quarter of 2023, primarily due to cumulative pre-tax losses, management determined a full valuation allowance was necessary to reduce the deferred tax assets to the amount that is more likely than not to be realized. During the third quarter of 2023, the Company released the valuation allowance previously recorded on its deferred tax assets. The Company concluded that, due to its established historical cumulative positive income before income taxes plus permanent differences for the recent years, projections of future taxable income, and the reversal of taxable temporary differences, the realization of deferred tax assets as of March 31, 2024 was more likely than not. The Company’s effective income tax rate was 24 % and ( 4 %) for the three months ended March 31, 2024 and 2023, respectively, differing from the U.S. corporate statutory federal income tax rate of 21 %. T he difference for the three months ended March 31, 2024 was primarily the effect of state income taxes and certain nondeductible permanent differences, partially offset by the utilization of research and development tax credits. The difference for the three months ended March 31, 2023 was primarily the result of the valuation allowance applied to reduce the Company’s deferred tax assets to the amount that is more likely than not to be realized. The Company assesses its income tax positions and records tax benefits for all years subject to examination based upon its evaluation of the facts, circumstances and information available at the reporting date. For those tax positions where it is more-likely-than-not that a tax benefit will be sustained, the Company has recorded the largest amount of tax benefit with a greater than 50% likelihood of being realized upon ultimate settlement with a taxing authority that has full knowledge of all relevant information. For those income tax positions where it is not more-likely-than-not that a tax benefit will be sustained, no tax benefit has been recognized in the Company’s financial statements. The Company continually evaluates expiring statutes of limitations, audits, proposed settlements, changes in tax law and new authoritative rulings. Due to the existence of net operating loss carryforwards since inception, all of the Company’s income tax filings remain open for tax examinations. The Company does no t have any material unrecognized tax benefits as of March 31, 2024 and December 31, 2023. |
Common Stock and Treasury Stock
Common Stock and Treasury Stock | 3 Months Ended |
Mar. 31, 2024 | |
Equity [Abstract] | |
Common Stock and Treasury Stock | 7. Common stock and treasury stock As of March 31, 2024 and December 31, 2023, the number of issued shares of common stock was 13,942,164 and 13,980,274 , respectively, which included shares of treasury stock of 202,000 and 9,428 , respectively. The changes in the number of issued shares of common stock and treasury stock were due to the following factors: • An aggregate of 67,125 shares of common stock were issued as a result of the vesting of RSUs, of which, 20,867 shares of common stock were withheld to pay withholding taxes upon such vesting, which were reflected in treasury stock, with a cost of $ 383 . Related treasury stock of 20,867 shares was then retired during the three months ended March 31, 2024. • On May 2, 2022, the board of directors of the Company authorized the repurchase of up to $ 5.0 million of the Company's common stock from time to time, and subsequently on each of December 19, 2023 and March 28, 2024, the board of directors authorized the repurchase of an additional $ 5.0 million of the Company's common stock (the "Stock Repurchase Program"). The Stock Repurchase Program does not obligate the Company to repurchase any shares and may be modified, suspended, or terminated at any time and for any reason at the discretion of the board of directors. During the three months ended March 31, 2024, the Company repurchased 276,940 shares of common stock under the Stock Repurchase Program, which was reflected in treasury stock, with a cost of $ 5,514 . Related treasury stock of 84,368 shares, with a cost of $ 1,559 , was retired during the three months ended March 31, 2024, which resulted in a treasury stock balance of $ 4,143 as of March 31, 2024. |
Share-based Compensation
Share-based Compensation | 3 Months Ended |
Mar. 31, 2024 | |
Share-Based Payment Arrangement [Abstract] | |
Share-based Compensation | 8. Share-based compensation On March 22, 2018, the board of directors of the Company and Cogint, Inc. (“cogint”) (now known as Fluent, Inc.), in its capacity as sole stockholder of the Company prior to the Company’s spin-off from cogint on March 26, 2018 (the “Spin-off”), approved the Red Violet, Inc. 2018 Stock Incentive Plan (the “2018 Plan”), which became effective immediately prior to the Spin-off. A total of 3,000,000 shares of common stock were authorized to be issued under the 2018 Plan. Subsequently on June 3, 2020 and May 25, 2022, the Company’s stockholders approved amendments to the 2018 Plan to increase the number of shares of common stock authorized for issuance under the 2018 Plan to 4,500,000 shares and 6,500,000 shares, respectively. The primary purpose of the 2018 Plan, as amended, is to attract, retain, reward and motivate certain individuals by providing them with an opportunity to acquire or increase a proprietary interest in the Company and to incentivize them to expend maximum effort for the growth and success of the Company, so as to strengthen the mutuality of the interests between such individuals and the stockholders of the Company. As of March 31, 2024, there were 1,907,155 shares of common stock available for future issuance under the 2018 Plan, as amended. To date, all stock incentives issued under the 2018 Plan, as amended, have been in the form of RSUs. RSUs granted under the 2018 Plan, as amended, vest and settle upon the satisfaction of a time-based condition or with both time- and performance-based conditions. The time-based condition for these awards is generally satisfied over three or four years with annual vesting. Details of unvested RSU activity during the three months ended March 31, 2024 were as follows: Number of units Weighted average Unvested as of December 31, 2023 1,017,718 $ 20.10 Granted (1) 214,150 $ 18.26 Vested and delivered ( 46,258 ) $ 25.49 Withheld as treasury stock (2) ( 20,867 ) $ 25.44 Forfeited ( 123,850 ) $ 16.71 Unvested as of March 31, 2024 1,040,893 $ 19.77 (1) In March 2024, the Company granted 130,000 RSUs, subject to performance-based requirements, to one non-executive employee at a grant date fair value of $ 18.30 per share. Such RSU grant shall not vest unless and until the Company has achieved certain revenue for a portion of its business prior to December 31, 2030, the last achievement date deadline. No amortization of share-based compensation expense has been recognized for 115,000 RSUs among the above-mentioned grant, because, as of March 31, 2024, the Company determined that it is not probable that related performance criteria will be met. In addition to the 130,000 RSUs discussed above, the Company granted, during the three months ended March 31, 2024, an aggregate of 84,150 RSUs to certain employees and one director at grant date fair values ranging from $ 18.12 to $ 18.30 per share, with a vesting period ranging from one to four years . (2) Withheld as treasury stock represents shares withheld to pay statutory taxes upon the vesting of RSUs. Refer to Note 7, "Common stock and treasury stock," for details. As of March 31, 2024, unrecognized share-based compensation expense associated with the granted RSUs amounted to $ 16,483 , which is expected to be recognized over a remaining weighted average period of 2.9 years. Share-based compensation was allocated to the following accounts in the condensed consolidated financial statements for the three months ended March 31, 2024 and 2023: Three Months Ended March 31, (In thousands) 2024 2023 Sales and marketing expenses $ 138 $ 107 General and administrative expenses 1,264 1,277 Share-based compensation expense 1,402 1,384 Capitalized in intangible assets 446 459 Total $ 1,848 $ 1,843 |
Leases
Leases | 3 Months Ended |
Mar. 31, 2024 | |
Leases [Abstract] | |
Leases | 9. Leases The Company leases its corporate headquarters of 21,020 rentable square feet in accordance with a non-cancellable 89 -month operating lease agreement as amended and effective in January 2017, with an option to extend for an additional 60 months . On September 20, 2023, the Company entered into an amendment to its corporate headquarters lease agreement to exercise the extension option for an additional 60 months through June 30, 2029, with an option to further extend for an additional 60 months . The Company also leases an additional office space of 6,003 rentable square feet in accordance with a non-cancellable 90 -month operating lease agreement entered into in April 2017, with an option to extend for an additional 60 months . The extension option is not included in the determination of the lease term as it is not reasonably certain to be exercised. For the three months ended March 31, 2024 and 2023, a summary of the Company’s lease information is shown below: Three Months Ended March 31, (In thousands) 2024 2023 Lease cost: Operating lease costs $ 194 $ 168 Other information: Cash paid for operating leases $ 194 $ 190 As of March 31, 2024, the weighted average remaining operating lease term was 4.7 years. As of March 31, 2024, scheduled future maturities and present value of the operating lease liabilities are as follows: (In thousands) Year March 31, 2024 Remainder of 2024 595 2025 580 2026 519 2027 535 2028 551 2029 and thereafter 279 Total maturities $ 3,059 Present value included in condensed consolidated balance sheet: Current portion of operating lease liabilities $ 588 Noncurrent operating lease liabilities 1,845 Total operating lease liabilities $ 2,433 Difference between the maturities and the present value of operating lease liabilities $ 626 |
Commitments and Contingencies
Commitments and Contingencies | 3 Months Ended |
Mar. 31, 2024 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | 10. Commitments and contingencies (a) Capital commitment The Company incurred data costs of $ 2,434 and $ 2,361 for the three months ended March 31, 2024 and 2023, respectively , under certain data licensing agreements. As of March 31, 2024, material capital commitments under certain data licensing agreements were $ 20,083 , shown as follows: (In thousands) Year March 31, 2024 Remainder of 2024 $ 6,488 2025 8,530 2026 4,839 2027 226 Total $ 20,083 (b) Contingencies The Company establishes accruals for those contingencies where the incurrence of a loss is probable and can be reasonably estimated, and it discloses the amount accrued and the amount of a reasonably possible loss in excess of the amount accrued, if such disclosure is necessary for its financial statements to not be misleading. To estimate whether a loss contingency should be accrued by a charge to income, the Company evaluates, among other factors, the degree of probability of an unfavorable outcome and the ability to make a reasonable estimate of the amount of the loss. The Company does not record liabilities when the likelihood that the liability has been incurred is probable, but the amount cannot be reasonably estimated. In addition to the foregoing, the Company may be involved in litigation from time to time in the ordinary course of business. The Company does not believe that the ultimate resolution of any such matters will have a material adverse effect on its business, financial condition, results of operations or cash flows. However, the results of such matters cannot be predicted with certainty and the Company cannot assure you that the ultimate resolution of any legal or administrative proceeding or dispute will not have a material adverse effect on its business, financial condition, results of operations and cash flows. |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 3 Months Ended |
Mar. 31, 2024 | |
Accounting Policies [Abstract] | |
Basis of Preparation | (a) Basis of preparation The accompanying unaudited condensed consolidated financial statements of Red Violet, Inc., a Delaware corporation, and its consolidated subsidiaries (collectively, “red violet” or the “Company”), have been prepared in accordance with accounting principles generally accepted in the United States (“US GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in annual financial statements prepared in accordance with US GAAP have been condensed or omitted pursuant to those rules and regulations. The accompanying unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the financial position, results of operations, and cash flows for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for any future interim periods or for the full year ending December 31, 2024. The information included in this quarterly report on Form 10-Q should be read in conjunction with the consolidated financial statements and accompanying notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 filed with the SEC on March 7, 2024 (“Form 10-K”). The condensed consolidated balance sheet as of December 31, 2023 included herein was derived from the audited financial statements as of that date included in the Form 10-K, but does not include all disclosures required by US GAAP. The Company has only one operating segment, as defined by Accounting Standards Codification (“ASC”) 280, “ Segment Reporting .” Principles of consolidation The condensed consolidated financial statements include the financial statements of the Company and its subsidiaries. All significant transactions among the Company and its subsidiaries have been eliminated upon consolidation. |
Recently Issued Accounting Standards | (b) Recently issued accounting standards In December 2023, the Financial Accounting Standard Board (the “FASB”) issued Accounting Standard Updates (“ASU”) No. 2023-09, " Income Taxes (Topic 740): Improvements to Income Tax Disclosures (ASU 2023-09) ," which improves the transparency of income tax disclosures by requiring consistent categories and greater disaggregation of information in the effective tax rate reconciliation and income taxes paid disaggregated by jurisdiction. It also includes certain other amendments to improve the effectiveness of income tax disclosures. This guidance will be effective for the annual periods beginning after December 31, 2024. Early adoption is permitted. Upon adoption, the guidance can be applied prospectively or retrospectively. The Company is currently evaluating the guidance to determine its impact on our condensed consolidated financial statements and related disclosures. |
Earnings per share (Tables)
Earnings per share (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Earnings Per Share [Abstract] | |
Schedule of Basic and Diluted Earnings Per Share | Basic earnings per share is computed by dividing net income by the weighted average number of shares of common stock outstanding during the periods. Diluted earnings per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock and is calculated using the treasury stock method for unvested shares. Three Months Ended March 31, (In thousands, except share data) 2024 2023 Numerator: Net income $ 1,784 $ 716 Denominator: Weighted average shares outstanding: Basic 13,997,064 13,997,154 Diluted (1) 14,164,506 14,236,771 Earnings per share: Basic $ 0.13 $ 0.05 Diluted $ 0.13 $ 0.05 (1) For the three months ended March 31, 2024 and 2023, diluted weighted average shares outstanding are calculated by the inclusion of unvested restricted stock units ("RSUs"). |
Intangible Assets, Net (Tables)
Intangible Assets, Net (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Intangible Assets, Net (Excluding Goodwill) [Abstract] | |
Intangible Assets Other than Goodwill | Intangible assets other than goodwill consist of the following: March 31, 2024 December 31, 2023 (In thousands) Amortization Gross amount Accumulated amortization Net Gross amount Accumulated amortization Net Software developed for internal use 5 - 10 years $ 66,318 $ ( 31,356 ) $ 34,962 $ 63,545 $ ( 29,142 ) $ 34,403 |
Schedule of Estimated Amortization Expense | As of March 31, 2024, estimated amortization expense related to the Company’s intangible assets for the remainder of 2024 through 2029 and thereafter are as follows: (In thousands) Year March 31, 2024 Remainder of 2024 $ 7,164 2025 8,753 2026 7,301 2027 5,685 2028 3,253 2029 and thereafter 2,806 Total $ 34,962 |
Share-based Compensation (Table
Share-based Compensation (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Share-Based Payment Arrangement [Abstract] | |
Schedule of Unvested Restricted Stock Units | Details of unvested RSU activity during the three months ended March 31, 2024 were as follows: Number of units Weighted average Unvested as of December 31, 2023 1,017,718 $ 20.10 Granted (1) 214,150 $ 18.26 Vested and delivered ( 46,258 ) $ 25.49 Withheld as treasury stock (2) ( 20,867 ) $ 25.44 Forfeited ( 123,850 ) $ 16.71 Unvested as of March 31, 2024 1,040,893 $ 19.77 (1) In March 2024, the Company granted 130,000 RSUs, subject to performance-based requirements, to one non-executive employee at a grant date fair value of $ 18.30 per share. Such RSU grant shall not vest unless and until the Company has achieved certain revenue for a portion of its business prior to December 31, 2030, the last achievement date deadline. No amortization of share-based compensation expense has been recognized for 115,000 RSUs among the above-mentioned grant, because, as of March 31, 2024, the Company determined that it is not probable that related performance criteria will be met. In addition to the 130,000 RSUs discussed above, the Company granted, during the three months ended March 31, 2024, an aggregate of 84,150 RSUs to certain employees and one director at grant date fair values ranging from $ 18.12 to $ 18.30 per share, with a vesting period ranging from one to four years . (2) Withheld as treasury stock represents shares withheld to pay statutory taxes upon the vesting of RSUs. Refer to Note 7, "Common stock and treasury stock," for details. |
Summary of Allocated Share-based Compensation | Share-based compensation was allocated to the following accounts in the condensed consolidated financial statements for the three months ended March 31, 2024 and 2023: Three Months Ended March 31, (In thousands) 2024 2023 Sales and marketing expenses $ 138 $ 107 General and administrative expenses 1,264 1,277 Share-based compensation expense 1,402 1,384 Capitalized in intangible assets 446 459 Total $ 1,848 $ 1,843 |
Leases (Tables)
Leases (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Leases [Abstract] | |
Summary of Company's Lease Information | For the three months ended March 31, 2024 and 2023, a summary of the Company’s lease information is shown below: Three Months Ended March 31, (In thousands) 2024 2023 Lease cost: Operating lease costs $ 194 $ 168 Other information: Cash paid for operating leases $ 194 $ 190 |
Scheduled Future Maturities and Present Value of Operating Lease Liabilities | As of March 31, 2024, scheduled future maturities and present value of the operating lease liabilities are as follows: (In thousands) Year March 31, 2024 Remainder of 2024 595 2025 580 2026 519 2027 535 2028 551 2029 and thereafter 279 Total maturities $ 3,059 Present value included in condensed consolidated balance sheet: Current portion of operating lease liabilities $ 588 Noncurrent operating lease liabilities 1,845 Total operating lease liabilities $ 2,433 Difference between the maturities and the present value of operating lease liabilities $ 626 |
Commitments and Contingencies (
Commitments and Contingencies (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Commitments and Contingencies Disclosure [Abstract] | |
Future Minimum Capital Payments under Certain Data Licensing Agreements | The Company incurred data costs of $ 2,434 and $ 2,361 for the three months ended March 31, 2024 and 2023, respectively , under certain data licensing agreements. As of March 31, 2024, material capital commitments under certain data licensing agreements were $ 20,083 , shown as follows: (In thousands) Year March 31, 2024 Remainder of 2024 $ 6,488 2025 8,530 2026 4,839 2027 226 Total $ 20,083 |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies - Additional Information (Details) | 3 Months Ended |
Mar. 31, 2024 Segment | |
Accounting Policies [Abstract] | |
Operating segments | 1 |
Earnings per share - Schedule o
Earnings per share - Schedule of Basic and Diluted Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | ||
Mar. 31, 2024 | Mar. 31, 2023 | ||
Earnings Per Share [Abstract] | |||
Net income | $ 1,784 | $ 716 | |
Weighted average shares outstanding: | |||
Basic | 13,997,064 | 13,997,154 | |
Diluted | [1] | 14,164,506 | 14,236,771 |
Earnings per share: | |||
Basic | $ 0.13 | $ 0.05 | |
Diluted | $ 0.13 | $ 0.05 | |
[1] For the three months ended March 31, 2024 and 2023, diluted weighted average shares outstanding are calculated by the inclusion of unvested restricted stock units ("RSUs"). |
Intangible Assets, Net - Intang
Intangible Assets, Net - Intangible Assets Other than Goodwill (Details) - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
Finite Lived Intangible Assets [Line Items] | ||
Intangible Assets, Net | $ 34,962 | $ 34,403 |
Software Developed for Internal Use | ||
Finite Lived Intangible Assets [Line Items] | ||
Intangible Assets, Gross Amount | 66,318 | 63,545 |
Intangible Assets, Accumulated Amortization | (31,356) | (29,142) |
Intangible Assets, Net | $ 34,962 | $ 34,403 |
Software Developed for Internal Use | Minimum | ||
Finite Lived Intangible Assets [Line Items] | ||
Amortization Period | 5 years | |
Software Developed for Internal Use | Maximum | ||
Finite Lived Intangible Assets [Line Items] | ||
Amortization Period | 10 years |
Intangible Assets, Net - Additi
Intangible Assets, Net - Additional Information (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Finite Lived Intangible Assets [Line Items] | ||
Amortization expenses | $ 2,214 | $ 1,858 |
Intangible assets that have not started amortization | 5,265 | |
Software Developed for Internal Use | ||
Finite Lived Intangible Assets [Line Items] | ||
Capitalized costs of internally-developed software | $ 2,773 | $ 2,732 |
Intangible Assets, Net - Schedu
Intangible Assets, Net - Schedule of Estimated Amortization Expense (Details) - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
Intangible Liability Disclosure [Abstract] | ||
Remainder of 2024 | $ 7,164 | |
2025 | 8,753 | |
2026 | 7,301 | |
2027 | 5,685 | |
2028 | 3,253 | |
2029 and thereafter | 2,806 | |
Intangible Assets, Net | $ 34,962 | $ 34,403 |
Goodwill - Additional Informati
Goodwill - Additional Information (Details) - USD ($) $ in Thousands | 3 Months Ended | ||
Mar. 31, 2024 | Mar. 31, 2023 | Dec. 31, 2023 | |
Goodwill Disclosure [Abstract] | |||
Goodwill | $ 5,227 | $ 5,227 | |
Date of annual goodwill impairment test | October 1 | ||
Goodwill impairment charges | $ 0 | $ 0 | |
Accumulated goodwill impairment loss | $ 0 |
Revenue Recognition - Additiona
Revenue Recognition - Additional Information (Details) - USD ($) $ in Thousands | 3 Months Ended | ||
Mar. 31, 2024 | Mar. 31, 2023 | Dec. 31, 2023 | |
Revenue Recognition [Line Items] | |||
Deferred revenue | $ 652 | $ 690 | |
Deferred revenue realization period | 12 months | ||
Deferred revenue recognized | $ 264 | ||
Revenue For Future Outstanding Performance Obligations | $ 23,174 | ||
Period over which subscription contract terms exceed | 12 months | ||
Unbilled accounts receivable, current | $ 841 | 829 | |
Unbilled accounts receivable, non current | 216 | $ 371 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-04-01 | |||
Revenue Recognition [Line Items] | |||
Revenue For Future Outstanding Performance Obligations | $ 8,932 | ||
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period | 9 months | ||
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01 | |||
Revenue Recognition [Line Items] | |||
Revenue For Future Outstanding Performance Obligations | $ 7,659 | ||
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period | 1 year | ||
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01 | |||
Revenue Recognition [Line Items] | |||
Revenue For Future Outstanding Performance Obligations | $ 3,669 | ||
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period | 1 year | ||
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-01-01 | |||
Revenue Recognition [Line Items] | |||
Revenue For Future Outstanding Performance Obligations | $ 2,582 | ||
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period | 1 year | ||
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2028-01-01 | |||
Revenue Recognition [Line Items] | |||
Revenue For Future Outstanding Performance Obligations | $ 287 | ||
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2029-01-01 | |||
Revenue Recognition [Line Items] | |||
Revenue For Future Outstanding Performance Obligations | $ 45 | ||
Customers With Pricing Contracts | |||
Revenue Recognition [Line Items] | |||
Percentage of Revenue | 78% | 75% | |
Transactional Customers | |||
Revenue Recognition [Line Items] | |||
Percentage of Revenue | 22% | 25% |
Income Taxes - Additional Infor
Income Taxes - Additional Information (Details) - USD ($) | 3 Months Ended | ||
Mar. 31, 2024 | Mar. 31, 2023 | Dec. 31, 2023 | |
Income Tax Disclosure [Abstract] | |||
Effective income tax rate, percentage | 24% | 4% | |
Statutory federal income tax rate | 21% | 21% | |
Percentage of tax benefits likelihood of being realized upon settlement of tax authority | greater than 50% | ||
Unrecognized tax benefits | $ 0 | $ 0 |
Common Stock and Treasury Sto_2
Common Stock and Treasury Stock - Additional Information (Details) - USD ($) $ in Thousands | 3 Months Ended | |||||
Mar. 31, 2024 | Mar. 31, 2023 | Mar. 28, 2024 | Dec. 31, 2023 | Dec. 19, 2023 | May 02, 2022 | |
Equity [Line Items] | ||||||
Common stock, shares issued | 13,942,164 | 13,980,274 | ||||
Treasury stock, issued shares | 202,000 | 9,428 | ||||
Increase in treasury stock resulting from shares withheld to cover statutory taxes | $ 383 | $ 31 | ||||
Treasury stock, value | $ 4,143 | $ 188 | ||||
Stock repurchase program, authorized amount | $ 5,000 | $ 5,000 | $ 5,000 | |||
Treasury stock shares | 202,000 | 9,428 | ||||
Stock Repurchase Program | ||||||
Equity [Line Items] | ||||||
Treasury stock, value | $ 4,143 | |||||
Retirement of treasury stock, Shares | 84,368 | |||||
Related treasury stock cost | $ 1,559 | |||||
Treasury stock shares | 276,940 | |||||
Treasury stock cost | $ 5,514 | |||||
Common Stock | ||||||
Equity [Line Items] | ||||||
Vesting of restricted stock units, Shares | 67,125 | 6,800 | ||||
Treasury stock | ||||||
Equity [Line Items] | ||||||
Increase in treasury stock resulting from shares withheld to cover statutory taxes, Shares | 20,867 | 1,561 | ||||
Increase in treasury stock resulting from shares withheld to cover statutory taxes | $ 383 | $ 31 | ||||
Retirement of treasury stock, Shares | 20,867 |
Share-based Compensation - Addi
Share-based Compensation - Additional Information (Details) - USD ($) $ in Thousands | 3 Months Ended | |||
Mar. 31, 2024 | May 25, 2022 | Jun. 03, 2020 | Mar. 22, 2018 | |
Restricted Stock Units (RSUs) | ||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Unrecognized share-based compensation costs in respect of granted RSUs | $ 16,483 | |||
Unrecognized share-based compensation remaining weighted average period | 2 years 10 months 24 days | |||
2018 Stock Incentive Plan | ||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Number of common stock authorized | 3,000,000 | |||
Common stock available for future issuance | 1,907,155 | |||
2018 Stock Incentive Plan | Maximum [Member] | ||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Number of common stock authorized | 6,500,000 | 4,500,000 |
Share-based Compensation - Sche
Share-based Compensation - Schedule of Unvested RSU Activity (Details) - Restricted Stock Units (RSUs) | 3 Months Ended | |
Mar. 31, 2024 $ / shares shares | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Unvested, Number of units Beginning balance | shares | 1,017,718 | |
Granted, Number of units | shares | 214,150 | [1] |
Vested and delivered, Number of units | shares | (46,258) | |
Withheld as treasury stock, Number of units | shares | (20,867) | [2] |
Forfeited, Number of units | shares | (123,850) | |
Unvested, Number of units Ending balance | shares | 1,040,893 | |
Unvested, Weighted average grant-date fair value, Beginning balance | $ / shares | $ 20.1 | |
Granted, Weighted average grant-date fair value | $ / shares | 18.26 | [1] |
Vested and delivered, Weighted average grant-date fair value | $ / shares | 25.49 | |
Withheld as treasury stock, Weighted average grant-date fair value | $ / shares | 25.44 | [2] |
Forfeited, Weighted average grant-date fair value | $ / shares | 16.71 | |
Unvested, Weighted average grant-date fair value, Ending balance | $ / shares | $ 19.77 | |
[1] In March 2024, the Company granted 130,000 RSUs, subject to performance-based requirements, to one non-executive employee at a grant date fair value of $ 18.30 per share. Such RSU grant shall not vest unless and until the Company has achieved certain revenue for a portion of its business prior to December 31, 2030, the last achievement date deadline. No amortization of share-based compensation expense has been recognized for 115,000 RSUs among the above-mentioned grant, because, as of March 31, 2024, the Company determined that it is not probable that related performance criteria will be met. In addition to the 130,000 RSUs discussed above, the Company granted, during the three months ended March 31, 2024, an aggregate of 84,150 RSUs to certain employees and one director at grant date fair values ranging from $ 18.12 to $ 18.30 per share, with a vesting period ranging from one to four years . Withheld as treasury stock represents shares withheld to pay statutory taxes upon the vesting of RSUs. Refer to Note 7, "Common stock and treasury stock," for details. |
Share-based Compensation - Sc_2
Share-based Compensation - Schedule of Restricted Stock Units Granted (Parenthetical) (Details) - $ / shares | 3 Months Ended | ||
Mar. 31, 2024 | Mar. 31, 2023 | ||
Employees And Directors | Minimum | |||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Vesting period | 1 year | ||
Employees And Directors | Maximum | |||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Vesting period | 4 years | ||
Restricted Stock Units (RSUs) [Member] | |||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Granted, Number of units | [1] | 214,150 | |
Grant date fair value | [1] | $ 18.26 | |
Restricted Stock Units (RSUs) [Member] | Employees And Directors | |||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Granted, Number of units | 84,150 | ||
Restricted Stock Units (RSUs) [Member] | Employees And Directors | Minimum | |||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Grant date fair value | $ 18.12 | ||
Restricted Stock Units (RSUs) [Member] | Employees And Directors | Maximum | |||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Grant date fair value | $ 18.3 | ||
Performance Based Restricted Stock Units | Non Executive Employee | |||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Granted, Number of units | 130,000 | 130,000 | |
Number of units, granted excluded amortization expense | 115,000 | ||
Grant date fair value | $ 18.3 | ||
[1] In March 2024, the Company granted 130,000 RSUs, subject to performance-based requirements, to one non-executive employee at a grant date fair value of $ 18.30 per share. Such RSU grant shall not vest unless and until the Company has achieved certain revenue for a portion of its business prior to December 31, 2030, the last achievement date deadline. No amortization of share-based compensation expense has been recognized for 115,000 RSUs among the above-mentioned grant, because, as of March 31, 2024, the Company determined that it is not probable that related performance criteria will be met. In addition to the 130,000 RSUs discussed above, the Company granted, during the three months ended March 31, 2024, an aggregate of 84,150 RSUs to certain employees and one director at grant date fair values ranging from $ 18.12 to $ 18.30 per share, with a vesting period ranging from one to four years . |
Share-based Compensation - Summ
Share-based Compensation - Summary of Allocated Share-based Compensation (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Share-based compensation recognized | ||
Share-based compensation expense | $ 1,402 | $ 1,384 |
Capitalized in intangible assets | 446 | 459 |
Total | 1,848 | 1,843 |
Sales and Marketing Expenses | ||
Share-based compensation recognized | ||
Share-based compensation expense | 138 | 107 |
General and Administrative Expenses | ||
Share-based compensation recognized | ||
Share-based compensation expense | $ 1,264 | $ 1,277 |
Related Party Transactions - Ad
Related Party Transactions - Additional Information (Details) - USD ($) $ in Thousands | 3 Months Ended | ||
Mar. 31, 2024 | Mar. 31, 2023 | ||
Related Party Transaction [Line Items] | |||
Share-based compensation expense | $ 1,402 | $ 1,384 | |
Restricted Stock Units (RSUs) | |||
Related Party Transaction [Line Items] | |||
Unvested shares granted in accordance with 2018 RSU agreement | [1] | 214,150 | |
[1] In March 2024, the Company granted 130,000 RSUs, subject to performance-based requirements, to one non-executive employee at a grant date fair value of $ 18.30 per share. Such RSU grant shall not vest unless and until the Company has achieved certain revenue for a portion of its business prior to December 31, 2030, the last achievement date deadline. No amortization of share-based compensation expense has been recognized for 115,000 RSUs among the above-mentioned grant, because, as of March 31, 2024, the Company determined that it is not probable that related performance criteria will be met. In addition to the 130,000 RSUs discussed above, the Company granted, during the three months ended March 31, 2024, an aggregate of 84,150 RSUs to certain employees and one director at grant date fair values ranging from $ 18.12 to $ 18.30 per share, with a vesting period ranging from one to four years . |
Leases - Additional Information
Leases - Additional Information (Details) - ft² | Mar. 31, 2024 | Sep. 20, 2023 | Apr. 30, 2017 | Jan. 31, 2017 |
Leases [Abstract] | ||||
Operating leases rentable square feet | 6,003 | 21,020 | ||
Operating lease agreement | 90 months | 89 months | ||
Operating lease, extended term | 60 months | 60 months | 60 months | |
Weighted average remaining operating lease | 4 years 8 months 12 days |
Leases - Summary of Company's L
Leases - Summary of Company's Lease Information (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Lease cost: | ||
Operating lease costs | $ 194 | $ 168 |
Other information: | ||
Cash paid for operating leases | $ 194 | $ 190 |
Leases - Summary of Company's_2
Leases - Summary of Company's Lease Information (Parenthetical) (Details) - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
Leases [Abstract] | ||
Operating lease liability | $ 2,433 | |
Right-of-use assets | $ 2,323 | $ 2,457 |
Leases - Scheduled Future Matur
Leases - Scheduled Future Maturities and Present Value of Operating Lease Liabilities (Details) - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
Leases [Abstract] | ||
Remainder of 2024 | $ 595 | |
2025 | 580 | |
2026 | 519 | |
2027 | 535 | |
2028 | 551 | |
2029 and thereafter | 279 | |
Total maturities | 3,059 | |
Present value included in consolidated balance sheet: | ||
Current portion of operating lease liabilities | 588 | $ 569 |
Noncurrent operating lease liabilities | 1,845 | $ 1,999 |
Total operating lease liabilities | 2,433 | |
Difference between the maturities and the present value of operating lease liabilities | $ 626 |
Commitments and Contingencies -
Commitments and Contingencies - Additional Information (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | ||
Data cost incurred | $ 2,434 | $ 2,361 |
Total capital commitment under certain data licensing agreements | $ 20,083 |
Commitments and Contingencies_2
Commitments and Contingencies - Future Minimum Capital Payments under Certain Data Licensing Agreements (Details) $ in Thousands | Mar. 31, 2024 USD ($) |
Commitments and Contingencies Disclosure [Abstract] | |
Remainder of 2024 | $ 6,488 |
2025 | 8,530 |
2026 | 4,839 |
2027 | 226 |
Total | $ 20,083 |